advertisement
Brignole-Baudouin F 9
Showing records 1 to 9 | Display all abstracts from Brignole-Baudouin F73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Cwerman-Thibault H
Molecular therapy. Methods & clinical development 2017; 5: 200-220
72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Datta S
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412
73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Lechauve C
Molecular therapy. Methods & clinical development 2017; 5: 200-220
72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Baudouin C; Brignole-Baudouin F
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412
73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Augustin S; Roussel D
Molecular therapy. Methods & clinical development 2017; 5: 200-220
72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Denoyer A
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412
73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Reboussin É
Molecular therapy. Methods & clinical development 2017; 5: 200-220
72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Cortopassi GA
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412
73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Mohammad A; Degardin-Chicaud J; Simonutti M; Liang H; Brignole-Baudouin F; Maron A; Debeir T; Corral-Debrinski M
Molecular therapy. Methods & clinical development 2017; 5: 200-220
